Recall Register

Food, drugs, devices › Unichem Pharmaceuticals Usa Inc

Drug recall: Hydrochlorothiazide Tablet USP 25 mg,1000- count bottle, Rx Only, Manufactured by: UNICHEM LABORATORIES LTD. Pilerne Ind

FDA enforcement event 71860 · Class II · initiated 30 Jul 2015 · status Terminated · terminated 19 Oct 2018

DrugVoluntary: Firm initiated1 product recordRochelle Park, NJ

FDA enforcement event 71860 is a drug recall by Unichem Pharmaceuticals Usa Inc of Rochelle Park, NJ, initiated 30 Jul 2015 and classified Class II, with 1 product record.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 52% of the 292 drug enforcement events initiated in 2015 carry the same class.

Status: Terminated, terminated 19 Oct 2018. Initiation: voluntary: firm initiated. Unichem Pharmaceuticals Usa Inc has 12 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Unichem Pharmaceuticals Usa Inc, Rochelle Park, NJ.

Reason for recall

"Presence of Foreign Tablet: A pharmacist found a clopidogrel tablet in the 1000-count bottle of hydrochlorothiazide 25 mg tablets."

Distribution

"Nationwide"

Product records

Recall numberProductQuantityClassStatusReport date
D-1352-2015Hydrochlorothiazide Tablet USP 25 mg,1000- count bottle, Rx Only, Manufactured by: UNICHEM LABORATORIES LTD. Pilerne Ind. Estate, Pilerne, Bardez, Goa 403 511, India Marketed by: UNICHEM PHARMACEUTICALS (USA), INC. Rochelle Park, NJ 07662, NDC 29300-128-104776 bottlesClass IITerminated2 Sep 2015

Context

52%of 2015 drug events are Class II292 events that year
1product record in this eventfirm median: 1
12events on this register for the firm

Other enforcement events for Unichem Pharmaceuticals Usa Inc

InitiatedProduct (first record)TypeClassRecords
13 Apr 2026busPIRone Hydrochloride Tablets, USP, 5 mg, 500-count bottle, Rx Only, Manufactured by Unichem Laboratories LTD., Ind, ADrugClass III1
21 Jan 2026Bisoprolol Fumarate and Hydrochlorothiazide tablets, USP, 2.5 mg/6.25 mg, 100-count bottle, Rx Only, Manufactured by: UNDrugClass II1
21 Jan 2026Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only, distributed by Unichem Pharmaceuticals (USA), Inc., 1 ToDrugClass III1
27 Aug 2025Cyclobenzaprine Hydrochloride Tablets, USP, 10 mg, 90-count bottle, RX only, Manufactured by: Unichem Laboratories, Ltd,DrugClass I1
19 Sep 2022Clonidine Hydrochloride Tablets, USP, 0.3 mg, 100-count bottle, Rx Only, Manufactured by: UNICHEM LABORATORIES LTD. PileDrugClass III1
25 Oct 2021Topiramate Tablets, USP 50 mg, 500-count bottles, Rx Only, Manufactured by: Unichem Laboratories LTD, Ind. Area. Meerut DrugClass III1
26 May 2020Clonidine Hydrochloride Tablets, USP 0.1 mg 100-count bottles, Rx only, Manufactured by: Unichem Laboratories LTD. PilerDrugClass III1
29 Jan 2020Clonidine Hydrochloride Tablets, USP 0.1mg, Rx Only, 100-count bottle, Manufactured by: Unichem Laboratories Ltd. PilernDrugClass III1
19 Dec 2017Divalproex Sodium Delayed Release Tablets USP, 500 mg, 100-count bottle, RX Only, Manufactured by: Unichem Laboratories DrugClass II1
2 Oct 2017Bisoprolol Fumarate tablets, 5 mg, 30-count bottles, Rx only, Manufactured by: UNICHEM LABORATORIES, LTD. Pilerne Ind. EDrugClass II1

All 12 events for Unichem Pharmaceuticals Usa Inc

Questions and answers

Why was this drug recalled?

FDA's record gives the reason for recall as: "Presence of Foreign Tablet: A pharmacist found a clopidogrel tablet in the 1000-count bottle of hydrochlorothiazide 25 mg tablets."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "Nationwide"

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 19 Oct 2018. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA drug enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.